Sternberg F, Meyerhoff C, Mennel F J, Hoss U, Mayer H, Bischof F, Pfeiffer E F
Institut für Diabetes-Technologie, Universität Ulm, Germany.
Horm Metab Res. 1994 Nov;26(11):523-5. doi: 10.1055/s-2007-1001748.
Continuous glucose monitoring is the conditio sine qua non to achieve total automation in glucose-controlled insulin-delivery. Several types of glucosensors have been designed according to the enzyme-amperometric method to measure the glucose in different human compartments. However, problems such as long-term stability and calibration prevent this technique being put into practice. A feasible method is needed to calibrate the glucosensor and at the same time should be accepted by the patients. To achieve calibration we determined the absolute tissue glucose, as well as the microdialysis recovery in-vivo, in healthy subjects under normal conditions and during a hyperglycaemic clamp by applying a device based on the recirculation of phosphate buffer saline in a microdialysis probe implanted in the s.c. adipose tissue. The first experiments carried out were promising and encouraging, but further investigations are still needed to favour an ideal "before implantation, all in-vitro" method to calibrate a s.c. glucosensor.
连续血糖监测是实现葡萄糖控制胰岛素给药完全自动化的必要条件。根据酶安培法设计了几种类型的葡萄糖传感器,用于测量人体不同部位的葡萄糖。然而,诸如长期稳定性和校准等问题阻碍了该技术的实际应用。需要一种可行的方法来校准葡萄糖传感器,同时该方法应能为患者所接受。为了实现校准,我们通过应用一种基于在植入皮下脂肪组织的微透析探针中循环磷酸盐缓冲盐水的装置,在正常条件下和高血糖钳夹期间,测定了健康受试者体内的绝对组织葡萄糖以及微透析回收率。最初进行的实验很有前景且令人鼓舞,但仍需要进一步研究,以支持一种理想的“植入前,全体外”方法来校准皮下葡萄糖传感器。